Lineage Cell Therapeutics (LCTX) Exchange Rate Effect (2010 - 2026)
Lineage Cell Therapeutics (LCTX) reported Exchange Rate Effect of -$5000.0 for Q1 2026, up 93.15% on a YoY basis from -$2588.7 in Q1 2025, and down 102.78% quarter-over-quarter from $180000.0 in Q4 2025.
Lineage Cell Therapeutics (LCTX) Exchange Rate Effect (2010 - 2026) Analysis & Trends
Lineage Cell Therapeutics has reported Exchange Rate Effect for 17 years, with the latest figure at -$5000.0 in Q1 2026.
- For the quarter ending Q1 2026, Exchange Rate Effect rose 93.15% year-over-year to -$5000.0; the trailing twelve-month figure through Mar 2026 stood at $464000.0 (up 573.47% YoY), and the FY2025 full-year result was $396000.0, up 516.84% from the prior year.
- Exchange Rate Effect for Q1 2026 stood at -$5000.0, down from $180000.0 in the prior quarter.
- The five-year high for Exchange Rate Effect was $293000.0 in Q2 2025, with the low at -$634000.0 in Q3 2022.
- Historically, Exchange Rate Effect has averaged -$48647.1 across 5 years, with a median of -$70000.0 in 2024.
- Annual changes were most pronounced in 2022 — Exchange Rate Effect slumped 7144.44% — and 2025, when it soared 620.0%.
- Lineage Cell Therapeutics' Exchange Rate Effect stood at -$78000.0 in 2022, then surged by 461.54% to $282000.0 in 2023, then sank by 91.13% to $25000.0 in 2024, then soared by 620.0% to $180000.0 in 2025, then plunged by 102.78% to -$5000.0 in 2026.
- The last three Exchange Rate Effect figures came in at -$5000.0 (Q1 2026), $180000.0 (Q4 2025), and -$4000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 3.60 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -2.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -40.30 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 8.68 Mn |
| 10 | Lineage Cell Therapeutics | 303.84 Mn | 239.94 Mn | 1.73 Mn | -5,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5,000.00 |
| Mar 31, 2026 | -5,000.00 |
| Dec 31, 2025 | 180,000.00 |
| Dec 31, 2025 | 180,000.00 |
| Sep 30, 2025 | -4,000.00 |
| Sep 30, 2025 | -4,000.00 |
| Jun 30, 2025 | 293,000.00 |
| Jun 30, 2025 | 293,000.00 |
| Mar 31, 2025 | -73,000.00 |
| Mar 31, 2025 | -73,000.00 |
| Dec 31, 2024 | 25,000.00 |
| Dec 31, 2024 | 25,000.00 |
| Sep 30, 2024 | 38,000.00 |
| Sep 30, 2024 | 38,000.00 |
| Jun 30, 2024 | -88,000.00 |
| Jun 30, 2024 | -88,000.00 |
| Mar 31, 2024 | -70,000.00 |
| Mar 31, 2024 | -70,000.00 |
| Dec 31, 2023 | 282,000.00 |
| Dec 31, 2023 | 282,000.00 |